Red White & Bloom Completes USD $6.12 million Non-Convertible Debenture Financing

Rhea-AI Summary

Red White & Bloom Brands Inc. announced the closure of a debenture unit financing, raising approximately USD 6,000,000 from an arm’s-length investor. The debenture is unsecured, non-convertible, with a 7% interest rate, and matures on April 1, 2022. Proceeds will support the expansion of its Platinum Vape business in Arizona, fund pre-closing operational plans for a THC Cultivation Center in Illinois, and provide general corporate working capital. The financing consists of USD 6,120,000 in debentures and 1,000,000 warrants exercisable at CDN$1.20 over two years.

Positive

• Raised approximately US $6,000,000 for business expansion.
• Funding allocated towards the launch of Platinum Vape in Arizona.
• Supports acquisition of a THC Cultivation Center License in Illinois.

Negative

• 7% interest rate on the debenture increases financial obligations.
• Potential dilution of shares if warrants are exercised.

TORONTO, Feb. 04, 2021 (GLOBE NEWSWIRE) -- Red White & Bloom Brands Inc. (CSE: RWB) (OTC: RWBYF) (“RWB” or the “Company”) announces that it closed a debenture unit financing to an arm’s-length investor on a private placement basis.

The Debenture is not convertible, unsecured and bears interest at the rate of 7% per annum. The principal amount of the Debenture and accrued interest is payable on April 1, 2022 (the “Maturity Date”).

The Company intends to utilize the proceeds from the Private Placement for the following:

1) The expansion of its Platinum Vape business as it prepares for its launch in Arizona;

2) Funding certain pre-closing operational plans for its previously announced acquisition of a THC Cultivation Center License and Associated Assets in Illinois;

3) General corporate and working capital.

The Debenture Unit consists of a USD $6,120,000 principal amount of debenture (the “Debenture”) and 1,000,000 common share purchase warrants (the “Warrants”) netting the Company approximately US $6,000,000 after fees and expenses. Each Warrant is exercisable into one common share of the Company at a price of CDN$1.20 for a period of 2 years from the date of issuance. All securities issued in connection with the Private Placement will be subject to a four-month hold period under securities laws.

About Red White & Bloom Brands Inc.

The Company is positioning itself to be one of the top three multi-state cannabis operators active in the U.S. legal cannabis and hemp sector. RWB is predominantly focusing its investments on the major US markets, including Michigan, Illinois, Massachusetts, Arizona and California with respect to cannabis, and the US and internationally for hemp-based CBD products.

For more information about Red White & Bloom Brands Inc., please contact:

Tyler Troup, Managing Director
Circadian Group IR
IR@RedWhiteBloom.com 

Visit us on the web: www.RedWhiteBloom.com 

Follow us on social media:
Twitter: @rwbbrands
Facebook: @redwhitebloombrands
Instagram: @redwhitebloombrands

Neither the CSE nor its Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.

FORWARD LOOKING INFORMATION

This press release contains forward-looking statements and information that are based on the beliefs of management and reflect the Company’s current expectations.  When used in this press release, the words “estimate”, “project”, “belief”, “anticipate”, “intend”, “expect”, “plan”, “predict”, “may” or “should” and the negative of these words or such variations thereon or comparable terminology are intended to identify forward-looking statements and information.  The forward-looking statements and information in this press release includes information relating to the implementation of the Company’s business plan and the PharmaCo acquisition.  Such statements and information reflect the current view of the Company with respect to risks and uncertainties that may cause actual results to differ materially from those contemplated in those forward-looking statements and information.

By their nature, forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause our actual results, performance or achievements, or other future events, to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements.  Such factors include, among others, the following risks: risks associated with the implementation of the Company’s business plan and matters relating thereto, risks associated with the cannabis industry, competition, regulatory change, the need for additional financing, reliance on key personnel, the potential for conflicts of interest among certain officers or directors, and the volatility of the Company’s common share price and volume.  Forward-looking statements are made based on management’s beliefs, estimates and opinions on the date that statements are made, and the Company undertakes no obligation to update forward-looking statements if these beliefs, estimates and opinions or other circumstances should change.  Investors are cautioned against attributing undue certainty to forward-looking statements.

There are a number of important factors that could cause the Company’s actual results to differ materially from those indicated or implied by forward-looking statements and information.  Such factors include, among others, risks related to the Company’s proposed business, such as failure of the business strategy and government regulation; risks related to the Company’s operations, such as additional financing requirements and access to capital, reliance on key and qualified personnel, insurance, competition, intellectual property and reliable supply chains; risks related to the Company and its business generally. The Company cautions that the foregoing list of material factors is not exhaustive. When relying on the Company’s forward-looking statements and information to make decisions, investors and others should carefully consider the foregoing factors and other uncertainties and potential events. The Company has assumed a certain progression, which may not be realized.  It has also assumed that the material factors referred to in the previous paragraph will not cause such forward-looking statements and information to differ materially from actual results or events. However, the list of these factors is not exhaustive and is subject to change and there can be no assurance that such assumptions will reflect the actual outcome of such items or factors. While the Company may elect to, it does not undertake to update this information at any particular time.

THE FORWARD-LOOKING INFORMATION CONTAINED IN THIS PRESS RELEASE REPRESENTS THE EXPECTATIONS OF THE COMPANY AS OF THE DATE OF THIS PRESS RELEASE AND, ACCORDINGLY, IS SUBJECT TO CHANGE AFTER SUCH DATE.  READERS SHOULD NOT PLACE UNDUE IMPORTANCE ON FORWARD-LOOKING INFORMATION AND SHOULD NOT RELY UPON THIS INFORMATION AS OF ANY OTHER DATE. WHILE THE COMPANY MAY ELECT TO, IT DOES NOT UNDERTAKE TO UPDATE THIS INFORMATION AT ANY PARTICULAR TIME EXCEPT AS REQUIRED IN ACCORDANCE WITH APPLICABLE LAWS. 

FAQ

What is the purpose of Red White & Bloom's recent financing?

The financing aims to expand its Platinum Vape business in Arizona, fund operations for its THC Cultivation Center in Illinois, and provide general working capital.

How much did Red White & Bloom raise from the debenture financing?

The company raised approximately US $6,000,000 from the debenture financing.

What are the terms of the debenture issued by Red White & Bloom?

The debenture is non-convertible, unsecured, carries a 7% annual interest rate, and matures on April 1, 2022.

What does the financing include in addition to the debenture?

The financing includes 1,000,000 common share purchase warrants, exercisable at a price of CDN$1.20 for two years.

What risks are associated with Red White & Bloom's financing?

The financing introduces a 7% interest rate financial obligation and the potential for share dilution if the warrants are exercised.